Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2022
Affiliations
Chinese Academy of Sciences(Current)
Linxiang Luo is an author at Chinese Academy of Sciences.
Publications per year
2022–2022
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma
Xi Chen, Haiying Kong, Linxiang Luo et al. · BMC Cancer · 2022 · 10 citations · Full text
1–1 of 1